Entry |
|
Name |
Bucindolol hydrochloride (USAN) |
Formula |
C22H25N3O2. HCl
|
Exact mass |
399.1714
|
Mol weight |
399.9137
|
Structure |
|
Class |
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG01462 beta2-Adrenergic receptor antagonist
|
Efficacy |
Antihypertensive |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
hsa04261 | Adrenergic signaling in cardiomyocytes |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG01462 beta2-Adrenergic receptor antagonist
D03170 Bucindolol hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D03170 Bucindolol hydrochloride (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 28
1 C8x C 19.5952 -17.7197
2 C8x C 19.5892 -16.3101
3 C8x C 18.3086 -18.4215
4 C8y C 18.3086 -15.6082
5 C8x C 17.0920 -17.7137
6 C8y C 17.0920 -16.3101
7 C3b C 15.8756 -15.6082
8 N3a N 14.6602 -14.9179
9 O2a O 18.3099 -14.2089
10 C1b C 19.5225 -13.5107
11 C1c C 20.7337 -14.2114
12 C1b C 21.9463 -13.5130
13 N1b N 23.1573 -14.2140
14 C1d C 24.3697 -13.5156
15 O1a O 20.7322 -15.6108
16 C1b C 25.5597 -14.2044
17 C8y C 26.7476 -13.5204
18 C1a C 25.5836 -12.8148
19 C1a C 23.1560 -12.8148
20 C8x C 26.7476 -12.1204
21 C8y C 28.0791 -13.9530
22 C8y C 28.9020 -12.8204
23 N4x N 28.0791 -11.6877
24 C8x C 28.6485 -15.2320
25 C8x C 30.0408 -15.3783
26 C8x C 30.8637 -14.2457
27 C8x C 30.2943 -12.9667
28 X Cl 28.0605 -17.5766
BOND 29
1 13 14 1
2 6 7 1
3 7 8 3
4 5 6 2
5 4 9 1
6 1 2 1
7 9 10 1
8 1 3 2
9 10 11 1
10 2 4 2
11 11 12 1
12 3 5 1
13 12 13 1
14 15 11 1
15 4 6 1
16 14 16 1
17 16 17 1
18 14 18 1
19 14 19 1
20 17 20 2
21 17 21 1
22 21 22 1
23 22 23 1
24 20 23 1
25 21 24 2
26 24 25 1
27 25 26 2
28 26 27 1
29 22 27 2
|